Nvidia's Big Bet: $50M Investment Fuels AI Drug Discovery at Recursion

Nvidia's Big Bet: $50M Investment Fuels AI Drug Discovery at Recursion

In this episode, we unpack the strategic move by Nvidia as it invests a substantial $50 million into Recursion, the AI-driven drug discovery firm. Join us as we explore the implications, collaborative potential, and the exciting intersection of technology and pharmaceutical innovation.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.